Gain of imprinting at chromosome 11p15: A pathogenetic mechanism identified in human hepatocarcinomas
about
Tumor suppressor candidate TSSC5 is regulated by UbcH6 and a novel ubiquitin ligase RING105Frequent loss of imprinting of IGF2 and MEST in lung adenocarcinomaInactivation of p57KIP2 by regional promoter hypermethylation and histone deacetylation in human tumorsMolecular cloning and characterization of a novel gene which is highly expressed in hepatocellular carcinoma.Mucins: a new family of epigenetic biomarkers in epithelial cancers.Cloning, expression and localization of human BM88 shows that it maps to chromosome 11p15.5, a region implicated in Beckwith-Wiedemann syndrome and tumorigenesisMultiple complementary transcripts of pCMa1, a novel gene located at chromosome 11p15.1-2, and melanocytic cell transformation.Silencing of imprinted CDKN1C gene expression is associated with loss of CpG and histone H3 lysine 9 methylation at DMR-LIT1 in esophageal cancer.Silencing of miR-370 in human cholangiocarcinoma by allelic loss and interleukin-6 induced maternal to paternal epigenotype switchLoss of imprinting and allelic switching at the DLK1-MEG3 locus in human hepatocellular carcinoma.DNA methylation, imprinting and cancer.MicroRNAs in liver cancer: a model for investigating pathogenesis and novel therapeutic approaches.Estrogen-mediated epigenetic repression of the imprinted gene cyclin-dependent kinase inhibitor 1C in breast cancer cells.Causes and consequences of DNA hypomethylation in human cancer.Characterization of SLC22A18 as a tumor suppressor and novel biomarker in colorectal cancer.DNA methylation as an adjunct to histopathology to detect prevalent, inconspicuous dysplasia and early-stage neoplasia in Barrett's esophagusMicroRNA involvement in hepatocellular carcinoma.Insulin-like growth factor II in hepatocellular carcinoma.Specific changes in the expression of imprinted genes in prostate cancer--implications for cancer progression and epigenetic regulation.Induction of MUC2 and MUC5AC mucins by factors of the epidermal growth factor (EGF) family is mediated by EGF receptor/Ras/Raf/extracellular signal-regulated kinase cascade and Sp1.Focal overexpression of insulin-like growth factor 2 by hepatocytes and cholangiocytes in viral liver cirrhosis.Microarray screening for target genes of the proto-oncogene PLAG1.A mechanistic role for the chromatin modulator, NAP1L1, in pancreatic neuroendocrine neoplasm proliferation and metastases.Deregulation of RB1 expression by loss of imprinting in human hepatocellular carcinoma.An information theoretic method to identify combinations of genomic alterations that promote glioblastoma.Development of targeted therapy for a broad spectrum of solid tumors mediated by a double promoter plasmid expressing diphtheria toxin under the control of IGF2-P4 and IGF2-P3 regulatory sequencesAlternative mechanisms associated with silencing of CDKN1C in Beckwith-Wiedemann syndrome.Aberrant expression of human mucin gene MUC5B in gastric carcinoma and cancer cells. Identification and regulation of a distal promoter.The Role of Long Non-Coding RNAs in Hepatocarcinogenesis.Loss of parental-specific methylation at the IGF2 locus in human hepatocellular carcinoma.
P2860
Q24297344-007CF8AA-7523-4913-BD44-E6C0BF568DBAQ28215251-D106FF4A-4DEF-4728-9B24-D0B33D935DA0Q28215348-D7984BB4-6E5A-4519-9D79-697AE005034DQ30165307-A4A97631-2530-45C8-9810-E9CAC59DE1B5Q30597703-1E934D95-A97D-458F-8D83-296F00A23FABQ30664234-421B0644-F202-42E0-A5FD-00EAB60907DFQ31107689-2E73C89F-83B7-4CC6-80E4-E29BC9E6F09BQ34303935-EC91EF49-9BCC-42C9-A59C-AEA3FE7C2146Q34460281-7890BB88-5A12-48DF-9F6A-685135278A0EQ34474525-1882EEB6-4039-42A9-9B1D-694F39052249Q34564994-2E52F63C-829B-4536-94B0-29F4DF59E220Q34675280-672C7A88-741E-4BD5-98B8-3880BA94C9B4Q35020435-3A680E1F-2491-45DC-994C-D0F083A641C2Q36164751-40768F0C-6660-4083-A468-102E8BAC7C79Q36413185-1FF002ED-BB9A-45C7-A30E-CACD0717FECEQ37207287-0BA47176-2D1D-46B5-A086-F5C48629E06DQ37361575-63564F10-E2D7-41F6-BBBA-A9AF44F001D5Q37755101-E64F7A52-EECA-49F5-957D-6BE66F403AECQ37988364-D932953A-5B1A-4417-A7EB-31C864832AE2Q38287931-B18816C6-4D58-45C5-810A-4D7A7007EDE7Q38293829-7044A727-3E7E-4876-AB6B-59FF558A7A7BQ38346182-FC13BF2D-6D34-4086-96F5-1A1DCC34268EQ38970716-169A69B3-D981-4F60-B3AB-E0671A3A85B8Q38994050-BC492691-EA87-40A8-9002-4F4479290A45Q40976160-AC8BA3D3-EBD8-414F-9D3C-54AD821A002AQ42049338-EACA70D9-296B-47E4-8AED-BABB413F53E3Q42140813-DAB6ADCD-A4D3-496D-81A4-9A6F4D14A23DQ48373208-774963AF-A004-44E9-98BA-33D6740958D9Q52370690-BC46E49F-2F58-4549-A3CB-0DB8122BAEBEQ54745586-26CB39A5-48D7-4D43-AA14-29434CA26B13
P2860
Gain of imprinting at chromosome 11p15: A pathogenetic mechanism identified in human hepatocarcinomas
description
2000 nî lūn-bûn
@nan
2000年の論文
@ja
2000年論文
@yue
2000年論文
@zh-hant
2000年論文
@zh-hk
2000年論文
@zh-mo
2000年論文
@zh-tw
2000年论文
@wuu
2000年论文
@zh
2000年论文
@zh-cn
name
Gain of imprinting at chromoso ...... fied in human hepatocarcinomas
@en
type
label
Gain of imprinting at chromoso ...... fied in human hepatocarcinomas
@en
prefLabel
Gain of imprinting at chromoso ...... fied in human hepatocarcinomas
@en
P2093
P2860
P356
P1476
Gain of imprinting at chromoso ...... fied in human hepatocarcinomas
@en
P2093
A Veronese
C Schwienbacher
G Barbanti-Brodano
L Gramantieri
P2860
P304
P356
10.1073/PNAS.090087497
P407
P577
2000-05-01T00:00:00Z